Ting Wang
- Pharmaceutical Science top 0.5%
- Advancements in Transdermal Drug Delivery 14
- Advanced Drug Delivery Systems 13
- Toxicology top 1%
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery 19
- Pharmacology top 1%
- Immunology top 5%
- Immunotherapy and Immune Responses 29
- Immune Response and Inflammation 12
-
- RNA Interference and Gene Delivery 16
- Lipid Membrane Structure and Behavior 13
-
- SARS-CoV-2 and COVID-19 Research 8
- Co-authors
- Mark A. WareStanley H. ShapiroJean‐Philippe ColletNing WangMinnan ChenTiefu LiNongyue HeYingjie Deng
- Journals
- Colloids and Surfaces B Biointerfaces (4 papers)Journal of Biomedical Nanotechnology (4 papers)European Journal of Pharmaceutical Sciences (4 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Ting Wang
172 papers receiving 4.3k citations
Peers
Comparison fields: 5 of 164
- Pharmaceutical Science 690
- Toxicology 180
- Biomaterials 642
- Pharmacology 803
- Immunology 665
Countries citing papers authored by Ting Wang
This map shows the geographic impact of Ting Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ting Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ting Wang more than expected).
Fields of papers citing papers by Ting Wang
This network shows the impact of papers produced by Ting Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ting Wang. The network helps show where Ting Wang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ting Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 6 | |
| 6 | 2024 | 6 | |
| 7 | 2023 | 2 | |
| 8 | 2023 | 7 | |
| 9 | 2023 | 7 | |
| 10 | 2023 | 7 | |
| 11 | 2023 | 8 | |
| 12 | 2021 | 4 | |
| 13 | 2020 | 6 | |
| 14 | 2020 | 2 | |
| 15 | 2015 | 24 | |
| 16 | 2015 | 15 | |
| 17 | 2013 | 0 | |
| 18 | 2011 | 3 | |
| 19 | 2010 | 35 | |
| 20 | 2006 | 11 |
About Ting Wang
Ting Wang is a scholar working on Pharmaceutical Science, Toxicology and Biomaterials, having authored 184 papers that have together received 4.4k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (29 papers), Nanoparticle-Based Drug Delivery (19 papers), RNA Interference and Gene Delivery (16 papers), Advancements in Transdermal Drug Delivery (14 papers), Advanced Drug Delivery Systems (13 papers), Lipid Membrane Structure and Behavior (13 papers), Immune Response and Inflammation (12 papers) and SARS-CoV-2 and COVID-19 Research (8 papers). The work is most often cited by research in Pharmaceutical Science (690 citations), Toxicology (180 citations) and Biomaterials (642 citations). Ting Wang has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Mark A. Ware, Stanley H. Shapiro, Jean‐Philippe Collet, Ning Wang, Ning Wang, Minnan Chen, Tiefu Li, Nongyue He, Yingjie Deng and G.J. Bennett. Their work appears in journals such as Colloids and Surfaces B Biointerfaces, Journal of Biomedical Nanotechnology, European Journal of Pharmaceutical Sciences, Journal of Controlled Release and European Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.